Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Millow is a Swedish biotechnology company that has developed a proprietary mycelium-based fermentation platform for the production of sustainable meat alternatives. The company's unique dry fermentation process allows for the growth of fungi into structured, whole-food products with high nutritional density and minimal processing. Unlike traditional fermentation methods, Millow's technology is highly resource-efficient, requiring significantly less water and energy. The company focuses on scaling its production through B2B partnerships with food manufacturers to integrate its mycelium protein into various consumer products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Millow.